Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Regulation of Coagulation by Polyphosphate

Nicola J. Mutch, BSc, PhD

Blood (2019) 134 (Supplement_1): SCI-18.

https://doi.org/10.1182/blood-2019-121062

Published: 2019

Journal Articles

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Naonori Harada, Takahiko Nakane, MD PhD, Mika Nakamae, MD PhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Yasunobu Takeoka, MD PhD, Asao Hirose, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2018) 132 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2018-99-111679

Published: 2018

Journal Articles

Survival after T-Cell Replete Haploidentical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor (MUD) Transplant for Lymphoid Malignancies

Alberto Mussetti, MD, Abraham Sebastian Kanate, MD, Mohamed A Kharfan-Dabaja, MD, Kwang Woo Ahn, PhD, Alyssa DiGilio, MS, Stefan O Ciurea, MD, Philippe Armand, MD PhD, Rachel B. Salit, MD, Timothy S. Fenske, MD MS, Sonali M. Smith, MD, Anna Sureda, MD PhD, Javier Bolanos-Meade, MD, Mehdi Hamadani, MD

Blood (2015) 126 (23): 194.

https://doi.org/10.1182/blood.V126.23.194.194

Published: 2015

Journal Articles

An Unexpected Role for Ribonuclease Inhibitor (RNH1) in Erythropoiesis

Ramanjaneyulu Allam, PhD, Vijaykumar Chennupati, PhD, Diogo F.T. Veiga, PhD, Kendle M Maslowski, PhD, Aubry Tardivel, MSc, Manfredo Quadroni, PhD, Michel Duchosal, MD, H Robson MacDonald, PhD, Nicolas Fasel, PhD, Anne Angelillo-Scherrer, MD, Pascal Schneider, PhD, Trang Hoang, PhD

Blood (2014) 124 (21): 244.

https://doi.org/10.1182/blood.V124.21.244.244

Published: 2014

Journal Articles

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Sebastian J. Swic, Alexander G. T. MacPhail, Chinmay B. Dalal, MD, Steven J.T. Huang, BMLSc, Alina S. Gerrie, MD FRCPC, Thomas J. Nevill, MD, Heather J. Sutherland, MD PhD FRCPC, Raewyn Broady, MBChB, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Kevin Song, MD, Yasser R Abou Mourad, MD FRCPC, Donna E. Hogge, MD PhD FRCPC, Maryse M. Power, MD MRCPI, FRCPath, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD, Sean S Young, PhD DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD FCCMG, Cynthia L. Toze, MD FRCPC

Blood (2014) 124 (21): 2549.

https://doi.org/10.1182/blood.V124.21.2549.2549

Published: 2014

Journal Articles

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Meera Sridharan, MD, PhD, Aref Al-Kali, MD, Aneel A. Ashrani, MBBS, MSc, Kebede Begna, MD, Michelle Elliott, William J. Hogan, MBChB, Carl C. Hook, MD, Scott H. Kaufmann, MD, PhD, Louis Letendre, MD, Mark R. Litzow, MD, Mrinal M. Patnaik, MBBS, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Alexandra Wolanskyj, MD, Rajiv K. Pruthi, MBBS

Blood (2013) 122 (21): 5000.

https://doi.org/10.1182/blood.V122.21.5000.5000

Published: 2013

Journal Articles

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

Peter Hillmen, MB ChB, PhD, Donald Milligan, MD, FRCP, FRCPath, Anna Schuh, MD, PhD, Lucy McParland, Anna Chalmers, Tahla Munir, MB ChB, Abraham M Varghese, MB ChB, Andy C Rawstron, BSc, PhD, David J Allsup, MD, PhD, Scott Marshall, MD, Alex Smith, BSc, Corinne Collett, Walter Gregory, PhD, Andrew Duncombe, MD, Dena Cohen, BSc, MSc

Blood (2013) 122 (21): 1639.

https://doi.org/10.1182/blood.V122.21.1639.1639

Published: 2013

Journal Articles

Clinical, Metabolic and Molecular Responses After 4 Courses of R-DHAP and After Autologous Stem Cell Transplantation for Untreated Mantle Cell Lymphoma Patients Included in the LyMa Trial, a Lysa Study

Steven Le Gouill, Mary Callanan, Elizabeth Macintyre, MD, PhD, marie-Hélène delfau-Larue, Caroline bodet-Milin, MD, Michel Meignan, MD, PhD, Anne Moreau, MD, Alexandra Travers-Glehen, Marie-christine Béné, Corinne Haouin, MD, Remy Gressin, MD, Rene-Olivier Casasnovas, MD, Vincent Ribrag, MD, Gandhi Damaj, MD, Emmanuel Gyan, MD, PhD, Lucie Oberic, Krimo Bouabdallah, MD, Catherine Thieblemont, MD, PhD, Olivier Hermine, MD, PhD

Blood (2012) 120 (21): 152.

https://doi.org/10.1182/blood.V120.21.152.152

Published: 2012

Journal Articles

In Vivo Modulation of Mitochondrial Activity Determines HSC Engraftment and Post-Transplant Survival in Mice

Nicola Vannini, PhD, Olaia M. Naveiras, MD, PhD, Vasco Campos, Eija Pirinen, PhD, Riekelt Houtkooper, Mukul Girotra, Aline Roch, Johan Auwerx, MD, PhD, Matthias Lutolf, PhD

Blood (2012) 120 (21): 213.

https://doi.org/10.1182/blood.V120.21.213.213

Published: 2012

Journal Articles

Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts

Blood (2012) 120 (21): 3748.

https://doi.org/10.1182/blood.V120.21.3748.3748

Published: 2012

Journal Articles

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Mark C Lanasa, MD, PhD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Han Tun, MD, Deborah A. Bowen, Diane F. Jelinek, Ph.D., Curtis A. Hanson, MD, Neil Kay, MD

Blood (2011) 118 (21): 3898.

https://doi.org/10.1182/blood.V118.21.3898.3898

Published: 2011

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Michal Sieniawski, MD, Malcolm Farrow, Xiao Zhao, Jennifer Wilkinson, Tryfonia Mainou-Fowler, Jo White, John MacIntyre, Stephen J. Proctor

Blood (2009) 114 (22): 1666.

https://doi.org/10.1182/blood.V114.22.1666.1666

Published: 2009

Journal Articles

Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia

Mohamad Mohty, Richard M. Szydlo, Agnes S. M. Yong, Jane F. Apperley, John M. Goldman, Junia V. Melo

Blood (2008) 112 (5): 2163–2166.

https://doi.org/10.1182/blood-2008-04-148130

Published: 2008

Journal Articles

PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment.

Carlo Finelli, MD, Matilde Y. Follo, PhD, Costanza Bosi, MD, Sara Mongiorgi, BS, Cristina Clissa, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Alberto M. Martelli, MD, PhD, Lucio Cocco, MD, PhD

Blood (2007) 110 (11): 2448.

https://doi.org/10.1182/blood.V110.11.2448.2448

Published: 2007

Journal Articles

Active Immunotherapy with FavId® (Id/KLH) Following Rituximab Induction: Long-Term Follow-Up of Response Rate Improvement (RRI) and Disease Progression in Follicular Lymphoma Patients (pts).

Omer N. Koc, MD, Charles Redfern, MD, Peter H. Wiernik, MD, Fred Rosenfelt, MD, Jane N. Winter, MD, Troy H. Guthrie, MD, Lawrence Kaplan, MD, Peter Holman, MD, John Densmore, MD, PhD, John Hainsworth, MD, Thomas S. Lin, MD, PhD, Rene A. Castillo, MD, Nalini Janakiraman, MD, Teresa Melink, NP, Song Liu, John Bender, PharmD

Blood (2006) 108 (11): 691.

https://doi.org/10.1182/blood.V108.11.691.691

Published: 2006

Journal Articles

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Houchingue Eghbali, MD, Pauline Brice, MD, Geert-Yan Creemers, MD, Marinus van Marwijk Kooij, MD, Patrice Carde, MD, Mars B. Van’t Veer, MD, Elli Lugtenburg, MD, Anne Sonet, MD, Catherine Sebban, MD, Michel Blanc, MD, John M. Raemaekers, MD, Laurent Voillat, MD, Chantal Rieux, Ed M. Noordijk, MD, Michel Henry-Amar, MD

Blood (2005) 106 (11): 814.

https://doi.org/10.1182/blood.V106.11.814.814

Published: 2005

Journal Articles

Single Immunophenotypical Evaluation of Minimal Residual Disease before Autotransplantation of Non-Cryopreserved Bone Marrow Is Insufficient for Prediction of Outcome in High Risk Adult Acute Lymphoblastic Leukemia.

Beata M. Stella-Holowiecka, MD, Krystyna Jagoda, MD, Aleksandra M. Holowiecka-Goral, MD, Tomasz Czerw, MD, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Jerzy Holowiecki, MD, PhD

Blood (2004) 104 (11): 4439.

https://doi.org/10.1182/blood.V104.11.4439.4439

Published: 2004

NARROW

Regulation of Coagulation by Polyphosphate

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Survival after T-Cell Replete Haploidentical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor (MUD) Transplant for Lymphoid Malignancies

An Unexpected Role for Ribonuclease Inhibitor (RNH1) in Erythropoiesis

Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

Clinical, Metabolic and Molecular Responses After 4 Courses of R-DHAP and After Autologous Stem Cell Transplantation for Untreated Mantle Cell Lymphoma Patients Included in the LyMa Trial, a Lysa Study

In Vivo Modulation of Mitochondrial Activity Determines HSC Engraftment and Post-Transplant Survival in Mice

Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia

PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment.

Active Immunotherapy with FavId® (Id/KLH) Following Rituximab Induction: Long-Term Follow-Up of Response Rate Improvement (RRI) and Disease Progression in Follicular Lymphoma Patients (pts).

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Single Immunophenotypical Evaluation of Minimal Residual Disease before Autotransplantation of Non-Cryopreserved Bone Marrow Is Insufficient for Prediction of Outcome in High Risk Adult Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only